Litcius/Paper detail

Beyond Glycemic Control: Cardiovascular, Renal, and Hepatic Benefits of GLP-1 Receptor Agonists

Dina M. Khodeer

2024Spectrum Science Journal10 citationsDOI

Topics & Concepts

GlycemicGlucagon-like peptide 1 receptorMedicineInternal medicineDiabetes mellitusEndocrinologyAgonistReceptorDiabetes Treatment and ManagementDiet and metabolism studiesPharmacology and Obesity Treatment
Beyond Glycemic Control: Cardiovascular, Renal, and Hepatic Benefits of GLP-1 Receptor Agonists | Litcius